Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals. Herein, we retrospectively compared the characteristics and outcomes of patients with hematologic malignancies (HMs) or hema...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Fungi (Basel)
Hlavní autoři: Axell-House, Dierdre B., Wurster, Sebastian, Jiang, Ying, Kyvernitakis, Andreas, Lewis, Russell E., Tarrand, Jeffrey J., Raad, Issam I., Kontoyiannis, Dimitrios P.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002622/
https://ncbi.nlm.nih.gov/pubmed/33802827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof7030217
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky